Details of Drug-Drug Interaction
| Drug General Information (ID: DDI5HLVCD4) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Tolcapone | Drug Info | Desipramine | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antiparkinson Agents | Antidepressants | |||||||
| Structure | |||||||||
| Mechanism of Tolcapone-Desipramine Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Tolcapone | Desipramine | |||||||
| Mechanism | Tolcapone | Increased incidence of adverse reactions may occur when taken concurrently with tolcapone | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Adverse reactions | ||||||||
| Factor Description | An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | The manufacturer recommends caution if desipramine is given to patients receiving tolcapone and levodopa/carbidopa. | ||||||||
